ObjectiveTo evaluate the efficacy of perifoveal tissue dissection (PTD) on patients undergoing pars plana vitrectomy for idiopathic macular holes of less than 1-year's duration.MethodsPars plana core vitrectomy was performed on 107 eyes of 104 consecutive patients with acute idiopathic macular holes. One cohort had routine PTD. In the other cohort, no attempt was made to strip preretinal tissue. Follow-up was longer than 6 months (follow-up range, 6 to 36 months).ResultsOverall, 95 (89%) of all macular holes were closed. Visual acuity improved 2 lines or more of the Snellen letter chart in 91 eyes (85%). A postoperative visual acuity of 20/50 or better was achieved in 79 eyes (74%). A transient increase in intraocular pressure (≥30 mm Hg) developed in 25 eyes (23.4%). In 6 eyes (5.6%) a retinal detachment developed. One eye had retinal pigment epithelial changes and 1 patient reported peripheral field loss. No statistically significant differences were noted between eyes having PTD and those without PTD for any outcome measure.ConclusionIn this series, no beneficial or adverse effect could be demonstrated by performing PTD in eyes undergoing pars plana core vitrectomy for acute idiopathic macular holes.IN 1991, KELLY and Wendelfirst reported a technique for the surgical repair of macular holes with an initial anatomical success rate of 58%. This rate increased to 83% in a series reported in 1994.Subsequent investigators modified various aspects of the technique in an attempt to improve the anatomical and visual results. Modifications included using various adjuvant treatments, including transforming growth factor-β2,autologous serum,thrombin,and platelet extracts.Others modified the duration of intraocular tamponadeor the need for postoperative prone positioning of the patient.Silicone oil has also been suggested as a substitute for long-acting gas to try to eliminate the need for prone positioning altogether or to use in patients unable to maintain a prone position because of physical limitations or age.The routine and meticulous removal of preretinal tissue and/or internal limiting membrane (ILM) has also been suggested as a means of improving surgical results.However, the role of removal of preretinal tissue and/or ILM in macular hole surgery is uncertain.This retrospective study describes the results obtained in 2 consecutive cohorts of eyes operated on for acute idiopathic macular holes. We reviewed a consecutive case series of 340 patients to determine whether preretinal tissue removal is beneficial in the treatment of acute idiopathic macular holes of less than 1 year's duration. In one cohort, all eyes underwent a meticulous attempt to dissect preretinal tissue and/or ILM from the foveal region. In the other cohort, no attempt was made to dissect preretinal tissue or ILM, even if the intraoperative appearance suggested the presence of a mild epiretinal membrane. Mild is defined as a glistening macular surface without an edge and without retinal striae or vascular straightening.MATERIALS AND METHODSWe reviewed 340 cases of idiopathic macular hole of less than 1 year's duration, performed in the 3-year period beginning December 1, 1994, extending to November 30, 1997.In reviewing operative notes, we found that 2 surgeons (R.R.M. and G.A.W.) in Associated Retinal Consultants, Royal Oak, Mich, performed the surgical procedure exactly the same way except that the first surgeon never attempted to peel preretinal tissue/ILM and the second surgeon always made an attempt to remove preretinal tissue/ILM. We believed that comparing the consecutive series of patients operated on by these 2 surgeons using the same time frame would give some indication as to the possible importance of perifoveal tissue dissection (PTD). Only primary operated on cases are considered, and any late reopening of an initially successfully closed hole was considered a surgical failure.One hundred seven eyes were included in this study. All met the criteria noted earlier and were operated on consecutively by the 2 surgeons between December 1, 1994, and November 30, 1997.A complete eye history was obtained and an ophthalmic examination was performed, including indirect ophthalmoscopy with scleral depression, evaluation of the macula with a 90-diopter lens or contact macular lens, and fundus photography with fluorescein angiography. In addition, a Watzke-Allen test was performed on each eye. In cases with an equivocal Watzke-Allen test result, microperimetry was done using the 50-µm laser aiming beam. Standardized visual acuity was obtained using an autorefractor (model 585; Allergan Humphrey, San Leandro, Calif) both preoperatively and postoperatively. Any complications were noted and treated as necessary.The surgical procedure was similar to that initially described by Kelly and Wendel.In all eyes, a 3-port pars plana core vitrectomy was performed. Next the vitrector with linear suction was used to separate the cortical vitreous from the optic nerve head. The cortical vitreous was then elevated from the retina over the macula and as far out to the periphery as possible, usually to the anterior equator. The elevated posterior hyaloid was then resected with the vitrector. A soft-tipped cannula with automated linear suction was then used to assure that the cortical vitreous had been completely removed.In cohort 1 (59 consecutive patients) a bent microvitreoretinal blade or a Rice ILM elevator (Synergetics Inc, Fort Collins, Colo) was used to dissect a plane between any preretinal tissue/ILM and the neurosensory retina. The preretinal tissue/ILM was typically identified as a glistening translucent sheet that could be elevated from the retina without retinal bleeding. The dissection was usually begun about 1000 µm from the center of the hole and continued circumferentially to the edge of the hole and at least 2 disc diameters from the center of the hole. The presence of retinal bleeding was used as an indication that the dissection of preretinal tissue/ILM was not proceeding successfully and the dissection was terminated. Successful dissection of the preretinal tissue/ILM was possible in approximately three quarters of the cases. This tissue was then removed with end-gripping forceps. In cohort 2 (48 consecutive patients), after stripping the posterior hyaloid and vitrectomy, no attempt was made to remove preretinal tissue. In both groups, following the waiting period, any additional preretinal fluid was removed with the soft-tipped cannula. The sclerotomy sites were closed and then 40 mL of 16% perfluoropropane gas was injected through the pars plana with a 30-gauge needle while a second 27-gauge needle, also passed through the pars plana, was used to vent the eye. Prone positioning of the patient was mandated for 2 weeks. Postoperative evaluations were done at days 1, 7, and 21 and at 3-month intervals thereafter. Follow-up ranged from 6 to 36 months.Visual acuities were converted to logMAR acuities for statistical analysis. Statistical analysis of the data was carried out using Statview (Abacus; Abacus Concepts Inc, Berkeley, Calif). Final visual outcomes between subgroups were compared using paired ttests. Categorical data such as anatomical hole closure were analyzed using a χ2or 2-tailed Fisher exact test.RESULTSTable 1summarizes the characteristics of the eyes included in this study. A total of 107 eyes from 104 patients met the criteria for inclusion in this study. Using the Gass classification, there were 13 stage 2 and 94 stage 3 macular holes. All eyes were operated on within 1 year of the development of the macular hole. Follow-up ranged from 6 to 36 months (mean length of follow-up, 13.4 months). Thirty-nine of the eyes were of male patients and 68 female patients, whose mean age was 69.7 years (age range, 48 to 88 years). Three cases were bilateral. There were 42 right eyes and 65 left eyes. Overall, preoperative visual acuities ranged from 20/50 to 20/400 with a mean visual acuity of 20/125. Postoperative visual acuities ranged from 20/20 to 20/400 with a mean visual acuity of 20/50. Postoperatively, 91 eyes (85%) improved 2 lines or more of the Snellen letter chart, with 79 (74%) achieving 20/50 or better visual acuity.Table 1. Baseline Data and Results*DataAll Eyes (N=107)Cohort 1†Cohort 2†Age, mean (range), y69.7 (48-88)69.969.4SexFemale68/107 (63.6)38/59 (64.4)30/48 (62.5)Male39/107 (36.4)21/59 (35.6)18/48 (37.5)Mean duration symptoms, mo2.872.912.81Stage of macular hole213/107 (12.1)4/59 (6.8)9/48 (18.7)394/107 (87.9)55/59 (93.2)39/48 (81.3)Macular hole closed95/107 (88.8)51/59 (86.4)44/48 (91.7)Macular hole closed by stage212/13 (92.3)4/4 (100)8/9 (88.9)383/94 (88.3)47/55 (85.4)36/39 (92.3)Mean preoperative visual acuity (Snellen)20/12520/12520/125Mean postoperative visual acuity (Snellen)20/5020/5620/43Eyes with visual acuity ≥20/5079/107 (73.8)38/59 (64.4)41/48 (84.5)Visual acuity improved 2 or more Snellen lines91/107 (85)48/59 (81.4)43/48 (89.6)Mean follow-up, mo13.413.412.8ComplicationsRetinal detachment6/107 (5.6)3/59 (5.1)3/48 (6.3)↑ IOP postoperatively‡25/107 (23.4)14/59 (23.7)11/48 (22.9)*The numerator indicates the number of affected patients; the denominator, the total number of patients enrolled in the study; and the parenthetical numbers, percentages.†Cohort 1 indicates eyes undergoing perifoveal tissue dissection; cohort 2, eyes without perifoveal tissue dissection.‡Transient elevation in intraocular pressure of 30 mm Hg or more.In cohort 1, the mean preoperative visual acuity was 20/125 and the mean postoperative visual acuity was 20/56. Postoperatively, 48 eyes (81%) improved 2 lines or more of the Snellen letter chart and 38 eyes (64%) were 20/50 or better. In cohort 2, the mean preoperative visual acuity was 20/125 and the mean postoperative acuity was 20/43. Postoperative visual acuity improved 2 lines or more of the Snellen letter chart in 43 eyes (90%) and was 20/50 or better in 41 eyes (85%).When comparing the overall mean preoperative visual acuity (20/125) to the overall mean postoperative visual acuity (20/50), the visual improvement was found to be highly significant (P<.001). Likewise, the visual improvements of each cohort were statistically significant (P<.001 ). When comparing the 2 groups for postoperative visual improvement, no statistical difference was noted between cohort 1 and cohort 2 (P=.07).When considering the number of eyes that improved to a visual acuity of 20/50 or better in each group, the difference between the peeled eyes (64%) and the nonpeeled eyes (85%) also showed statistical significance P=.01. However, this statistical significance was lost when we looked at subgroup analysis and considered the greater number of eyes with stage 2 macular holes in the nonpeeled cohort. Overall, there were 13 eyes with stage 2 holes. In cohort 1 there were 4 (6.8%) and in cohort 2 there were 9 (18.7%). This difference approached statistical significance (P=.059).Successful anatomical macular hole closure was achieved in 95 eyes (88.8%). The macular hole was closed in 51 (86.4%) of the 59 eyes where PTD was performed. In the 48 eyes without PTD, the hole was anatomically closed in 44 eyes (91.7%). This difference was not statistically significant (P=.39).Complications noted intraoperatively and postoperatively consisted of 25 eyes with transient elevations of intraocular pressure (≥30 mm Hg), 6 with retinal detachment, 1 eye with retinal pigment epithelial changes, and 1 eye with visual field loss. All eyes with intraocular pressure elevations were easily managed medically. Fourteen (24%) occurred in the eyes that had PTD and 11 (23%) in eyes that had no stripping. Of the 6 retinal detachments, 3 (5.1%) occurred in eyes that were peeled and 3 (6.3%) in the eyes that were not peeled. This difference was not statistically significant (P=.79). The eyes with the retinal pigment epithelial changes and the field loss were both in cohort 1.The average duration of symptoms in all eyes operated on was 2.87 months, (2.91 months for the peeled eyes and 2.81 months for the nonpeeled eyes; P=.81). Mean length of follow up was 13.4 months in cohort 1 and 12.8 months in cohort 2 (P=.538).The eyes in this study were operated on over a 3-year period. Table 2summarizes the successfully closed macular holes with respect to the year operated on. In the first year, December 1, 1994, to November 30, 1995, a total of 44 eyes were included in the study. Thirty-five (79.5%) of the macular holes were successfully closed. This rate improved to 34 (96.3%) of the 36 macular holes in the last year. Similar improvements occurred in each of the 2 cohorts. No statistically significant difference was noted between cohort 1 and 2 in any of the years. However, a statistically significant improvement was noted in the rate of closure between years 1 and 3 overall (P=.047).Table 2. Effect of Learning Curve on Rate of Closure of Acute Macular Holes*Study YearOverall (N=107)Cohort 1†Cohort 2†135/44 (79.5)22/29 (75.9)13/15 (86.7)234/36 (94.4)18/19 (94.7)16/17 (94.1)326/27 (96.3)11/11 (100)15/16 (93.8)*The numerator indicates the number of affected patients; the denominator, the total number of patients enrolled in the study; and parenthetical numbers, percentages.†Cohort 1 indicates eyes undergoing perifoveal tissue dissecting; cohort 2, eyes without perifoveal tissue dissection.COMMENTIn their landmark paper, Kelly and Wendelreported a 58% anatomical success rate in closing macular holes, with 42% of the eyes achieving a visual improvement of 2 lines or more and 25% attaining 20/50 or better vision. Since that initial report, they and othershave reported improved anatomical success rates and better visual results. These improvements have been attributed to the use of various adjuvant treatment and modifications in the surgical techniques. Improvements may be attributed to better patient selection, surgeon experience, and compliance with postoperative prone positioning.Articles discussing the management of macular holes often include epiretinal membrane dissection as an integral part of the surgical procedure. Some indicate that epiretinal membrane stripping is important to achieving surgical success.One article described a series of patients where epiretinal membrane stripping was specifically omitted.This article attributed the success rate achieved to the use of transforming growth factor-β2. We were unable to find an article that specifically compared the presence or absence of PTD in 2 similar groups of patients.Previous authorsreported a significant improvement in rates of closure of macular holes with the use of PTD. In all of these series, however, no attempt was made to compare eyes operated on contemporaneously. Rather, the series compare eyes operated on before and after the institution of PTD. Subtle improvements in surgical technique or surgeon experience may be overlooked in such a comparison. This seems to be the case in our series in which the overall results of successful macular hole closure improved from 79.5% in the eyes operated on in the first year compared with 96.3% of eyes operated on in the third year. This difference occurred despite the fact that the surgeons performing the operations had each performed more than 50 similar operations prior to December 1, 1994, when the first eye in our series was operated on.After reviewing the operative notes and interviewing the fellows who assisted in these cases, no specific differences in technique or follow-up could be determined. We speculate that incomplete removal or delamination of the posterior vitreous cortex in some of the earlier cases, as we have previously reported,may have been responsible for some of the failures. Delamination of the vitreous cortex can be present and remain undetected even in eyes that have undergone meticulous preretinal membrane dissection.We believe that if during the air-fluid exchange, the soft-tipped cannula engages any residual cortical vitreous on the optic disc or over the posterior pole, it is prudent to remove the air and attempt to remove any remaining cortical vitreous before completing the operation.In our study, we attempted to define the role, if any, of meticulous PTD in the management of acute idiopathic macular holes. In this series of 107 acute idiopathic macular holes, we noted no significant differences in visual acuity or anatomical results between groups before or after surgery. The cohort that did not undergo PTD had slightly better clinical results for anatomical attachment and visual results than the second group, although this was not statistically significant. The complication rates were comparable.One might theorize that the visual results would be better in the cohort with PTD. Removal of this tissue might result in less metamorphopsia and improved visual acuity. However, this did not appear to be the case here. Conversely, it has also been considered that manipulation of the perifoveal tissue might cause damage to the neurosensory retina or the underlying retinal pigment epithelium, resulting in poorer visual results.However, except in the 1 eye demonstrating retinal pigment epithelial disruption and poor vision, we did not demonstrate this to be the case.Six eyes (5.6%) in this series developed rhegmatogenous retinal detachment, postoperatively. This occurred despite careful preoperative, intra-operative, and postoperative examination of the retinal periphery in every case. No exudative retinal detachments occurred. This incidence compares favorably with previous reports and emphasizes the need for careful follow-up of this patient population. The incidence of retinal detachment in previous series was between 0% and 14%.This study demonstrated no beneficial or adverse effects of PTD on the rates of anatomical closure or postoperative visual improvement in acute idiopathic macular holes. This suggests that other factors such as postoperative positioning may be more important to anatomical and visual success than PTD. However, a randomized trial is necessary to definitely define the role of PTD in optimizing visual recovery after macular hole surgery.NEKellyRTWendelVitreous surgery for idiopathic macular holes: results for a pilot study.Arch Ophthalmol.1991;109:654-659.ACPatelRTWendelVitrectomy for macular hole.Semin Ophthalmol.1994;9:47-55.BMGlaserRGMichelsBDKuppermannRNSjaardaRAPenaTransforming growth factor-beta 2 for the treatment of full-thickness macular holes: a prospective randomized study.Ophthalmology.1992;99:1162-1173.PELiggettSASkolidBHorieHuman autologous serum for the treatment of full-thickness macular holes: a preliminary study.Ophthalmology.1995;102:1071-1076.JAWellsZJGregorSurgical treatment of full-thickness macular holes using autologous serum.Eye.1996;10:593-599.ADVineMWJohnsonThrombin in the management of full thickness macular holes.Retina.1996;16:474-478.TWOlsenPSternbergDFMartinACapone JrJLLimTMAabergPostoperative hypopyon after intravitreal bovine thrombin for macular hole surgery.Am J Ophthalmol.1996;121:575-577.AGaudricPMassinMPaquesMBrangerJEGuezTHuang-XuanAutologous platelet concentrate for the treatment of full-thickness macular holes.Graefes Arch Clin Exp Ophthalmol.1995;233:549-554.JFKorobelnikDHannoucheNBelayachiAutologous platelet concentrate as an adjunct in macular hole healing: a pilot study.Ophthalmology.1996;103:590-594.JTThompsonBMGlaserRNSjaardaRPMurphyAHanhamEffects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-β2.Ophthalmology.1994;101:1195-1200.PETornambeLSPolinerKGroteMacular hole surgery without face-down positioning; a pilot study.Retina.1997;17:179-185.MHGoldbaumBWMcCuenAMHannekenSKBurgessHHChenSilicone oil tamponade to seal macular holes without position restrictions.Ophthalmology.1998;105:2140-2147.RTWendelACPatelNEKellyTCSalzanoJWWellsGDNovackVitreous surgery for macular holes.Ophthalmology.1993;100:1671-1676.TARiceInternal limiting membrane removal in surgery for full-thickness macular holes.In: Madreperla SA, McCuen BW, eds. Macular Hole: Pathogenesis, Diagnosis, and Treatment.Boston, Mass: Butterworth/Heinemann; 1998:125-146.EHRyanHDGilbertResults of surgical treatment of recent-onset full thickness idiopathic macular holes.Arch Ophthalmol.1994;112:1545-1553.AWWillisJFGarcia-CosioMacular hole surgery: comparison of longstanding versus recent macular holes.Ophthalmology.1996;103:1811-1814.WESmiddySPimentelGAWilliamsMacular hole surgery without using adjunctive additives.Ophthalmic Surg Lasers.1997;28:713-717.MBLansingBMGlaserHLissThe effect of pars plana vitrectomy and transforming growth factor-β2without epiretinal membrane peeling on full-thickness macular holes.Ophthalmology.1993;100:868-872.ARMargherioRRMargherioMHartzerMTTreseGAWilliamsPJFerronePlasmin enzyme assisted vitrectomy in traumatic pediatric macular holes.Ophthalmology.1998;105:1617-1620.ASBankerWRFreemanJWKimDMunguraSPAzenVision-threatening complications of surgery for full-thickness macular holes.Ophthalmology.1997;104:1442-1453.SSParkDMMarcusJSDukerPosterior segment complications after vitrectomy for macular hole.Ophthalmology.1995;102:775-781.Accepted for publication November 10, 1999.Presented in part at the 21st meeting of Club Jules Gonin, Edinburgh, Scotland, August 31, 1998; The Retina Society, Washington, DC, September 25, 1998; and the American Academy of Ophthalmology, New Orleans, La, November 10, 1998.Drs Chow and Banach were fellows at the Beaumont Eye Institute, Royal Oak, Mich, and at Oakland University, Eye Research Institute, Rochester, Mich.Reprints: Raymond R. Margherio, MD, 632-3535 W 13 Mile Rd, Suite 555, Royal Oak, MI 48073 (e-mail: firstname.lastname@example.org).
JAMA Ophthalmology – American Medical Association
Published: Apr 1, 2000
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera